Today: 23 May 2026
Strategy (MSTR) stock jumps after-hours on 11% preferred dividend move — what traders are watching next
2 January 2026
2 mins read

Strategy (MSTR) stock jumps after-hours on 11% preferred dividend move — what traders are watching next

NEW YORK, January 2, 2026, 17:30 ET — After-hours

  • Strategy shares climbed after the company disclosed a higher dividend rate on its STRC preferred stock in an SEC filing.
  • Crypto-linked stocks firmed as bitcoin rose, keeping Strategy in focus as a high-beta proxy for the token.
  • Investors are watching bitcoin’s next move and upcoming U.S. data for clues on risk appetite.

Strategy Inc shares were up about 3.5% at $157.16 in after-hours trading on Friday, after a sharp session that ranged from $150.03 to $160.76. Trading volume was about 20 million shares.

The move matters because Strategy has become a bellwether “bitcoin treasury” trade, and small changes in how it funds itself can ripple through both its common stock and its yield-heavy preferred shares. Investors have focused on the company’s cost of capital as it leans on multiple security types to finance its bitcoin strategy.

Broader risk appetite also set the backdrop on the first trading day of 2026, with U.S. stocks ending mixed. “Buy the dip, sell the rip,” is the dominant mindset, Joe Mazzola, head of trading & derivatives strategy at Charles Schwab, told Reuters. Reuters

In a filing dated Dec. 31, Strategy said it lifted the regular annual dividend rate on its Variable Rate Series A Perpetual Stretch Preferred Stock — ticker STRC — to 11.00% from 10.75% for monthly periods beginning on or after Jan. 1. The company also said its board declared a cash dividend of $0.916666667 per STRC share for the month ending Jan. 31, payable on Jan. 31 to holders of record on Jan. 15.

Preferred stock is a class of equity that typically pays a dividend and ranks ahead of common shares for payouts. “Perpetual” means it has no set maturity date, while “variable-rate” means the dividend can reset, in this case monthly.

Bitcoin was up about 1.9% at roughly $90,114, while crypto-linked stocks also advanced, with Coinbase up about 4.6% and Marathon Digital up about 10.2%.

Strategy’s stock often moves more than bitcoin because investors treat it as a leveraged proxy — its balance-sheet exposure can amplify swings when the token rises or falls. That dynamic can also cut both ways when bitcoin volatility spikes.

Strategy says its treasury strategy is built around giving investors “varying degrees of economic exposure to Bitcoin” through a mix of securities, alongside its enterprise analytics software business. Strategy

On its STRC product page, the company says the preferred’s dividend rate is adjusted monthly to encourage trading around its $100 stated amount, and it notes the cash dividend is not guaranteed.

Near-term, traders will be watching whether bitcoin’s rebound holds and whether rates and the dollar shift as U.S. data flow normalizes after holiday-thinned trading. Reuters reported markets are focused on the Fed outlook and upcoming employment data.

The next major scheduled check-in for Strategy is its quarterly results window in early February; Nasdaq lists an estimated earnings date of Feb. 4. Investors typically look for any updates on funding costs, preferred dividend mechanics, and the company’s bitcoin-related disclosures.

For now, Strategy remains a fast-moving trade tied to crypto direction — and to how confidently investors think its financing model can keep working in both calm and volatile markets.

Stock Market Today

  • Haemonetics Q1 Earnings Beat Estimates Amid Strong Medical Devices Sector Performance
    May 22, 2026, 10:52 PM EDT. Haemonetics (NYSE:HAE) posted a robust Q1 with revenues of $346.4 million, up 4.8% year on year and exceeding analyst forecasts by 2.6%. The medical devices & supplies specialty sector outperformed expectations, with revenues beating consensus by 5.2% overall. Haemonetics shares rose 10.6% post-earnings to $58.27, reflecting investor confidence. Industry growth drivers include an aging population increasing demand for blood-related medical products and advances in digital health technology, while challenges remain from pricing pressures and regulatory demands. The sector saw steady stock performance, up 3.6% on average following earnings releases. STAAR Surgical also delivered strong results, highlighting sector momentum.

Latest articles

Dow Hits Record Close; All Eyes Turn to Holiday-Week Trading

Dow Hits Record Close; All Eyes Turn to Holiday-Week Trading

23 May 2026
The Dow closed at a record 50,579.70 on Friday, while the S&P 500 notched its eighth straight weekly gain. After-hours trading saw SPY, QQQ, DIA, and IWM all move lower. U.S. markets will be closed Monday for Memorial Day. Investors await Thursday’s inflation data.
IREN Stock Pauses as Nvidia Rally Cools Before Holiday

IREN Stock Pauses as Nvidia Rally Cools Before Holiday

23 May 2026
IREN shares fell 2.1% to $56.83 Friday, ending a two-day rally but closing the week up 7.4%. The stock’s moves follow a $3.4 billion AI cloud deal with Nvidia and a $3 billion convertible note offering. March-quarter revenue dropped to $144.8 million, with a net loss of $247.8 million. U.S. markets close Monday for Memorial Day; trading resumes Tuesday.
AXT stock reaches record; investors weigh risk to rally

AXT stock reaches record; investors weigh risk to rally

23 May 2026
AXT shares jumped 16.37% to $140.83 on Friday, hitting a 52-week high and trading above all recent analyst targets. The surge followed strong demand for AI-linked optical networking hardware and a sharp rise in indium phosphide orders. First-quarter revenue climbed to $26.9 million, with gross margin turning positive. Management forecast Q2 profitability and a backlog over $100 million.
Broadcom stock today: AVGO holds gains after hours as CFO sale notice and chip rally grab attention
Previous Story

Broadcom stock today: AVGO holds gains after hours as CFO sale notice and chip rally grab attention

Eli Lilly stock (LLY) edges higher after hours today as drug-pricing reset and January catalysts loom
Next Story

Eli Lilly stock (LLY) edges higher after hours today as drug-pricing reset and January catalysts loom

Go toTop